- Home
- TSAT vs ABEO Comparison
TSAT vs ABEO Comparison
Compare TSAT & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- ABEO
- Stock Information
- Founded
- TSAT 1969
- ABEO 1974
- Country
- TSAT Canada
- ABEO United States
- Employees
- TSAT N/A
- ABEO N/A
- Industry
- TSAT Metal Fabrications
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- TSAT Industrials
- ABEO Health Care
- Exchange
- TSAT Nasdaq
- ABEO Nasdaq
- Market Cap
- TSAT 233.1M
- ABEO 256.9M
- IPO Year
- TSAT 1996
- ABEO 1980
- Fundamental
- Price
- TSAT $15.86
- ABEO $6.28
- Analyst Decision
- TSAT
- ABEO Strong Buy
- Analyst Count
- TSAT 0
- ABEO 6
- Target Price
- TSAT N/A
- ABEO $18.00
- AVG Volume (30 Days)
- TSAT 59.6K
- ABEO 1.6M
- Earning Date
- TSAT 05-06-2025
- ABEO 05-15-2025
- Dividend Yield
- TSAT N/A
- ABEO N/A
- EPS Growth
- TSAT N/A
- ABEO N/A
- EPS
- TSAT N/A
- ABEO N/A
- Revenue
- TSAT $372,642,710.00
- ABEO N/A
- Revenue This Year
- TSAT N/A
- ABEO N/A
- Revenue Next Year
- TSAT N/A
- ABEO $383.07
- P/E Ratio
- TSAT N/A
- ABEO N/A
- Revenue Growth
- TSAT N/A
- ABEO N/A
- 52 Week Low
- TSAT $7.21
- ABEO $3.93
- 52 Week High
- TSAT $25.38
- ABEO $7.32
- Technical
- Relative Strength Index (RSI)
- TSAT 43.85
- ABEO 57.21
- Support Level
- TSAT $15.42
- ABEO $5.93
- Resistance Level
- TSAT $17.56
- ABEO $7.17
- Average True Range (ATR)
- TSAT 0.90
- ABEO 0.42
- MACD
- TSAT 0.02
- ABEO -0.01
- Stochastic Oscillator
- TSAT 15.12
- ABEO 52.15
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.